GENECAPS Trademark

Trademark Overview

On Saturday, December 14, 2019, a trademark application was filed for GENECAPS with the United States Patent and Trademark Office. The USPTO has given the GENECAPS trademark a serial number of 88727402. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, May 20, 2022. This trademark is owned by Calimmune, Inc.. The GENECAPS trademark is filed in the Pharmaceutical Products category with the following description:

Non-viral vectors in the form of nanoscale matrices, namely, pharmaceutical preparations for the delivery of therapeutic agents for the treatment or prevention of diseases affecting the immune system or hematologic system
genecaps

General Information

Serial Number88727402
Word MarkGENECAPS
Filing DateSaturday, December 14, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, May 20, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesNon-viral vectors in the form of nanoscale matrices, namely, pharmaceutical preparations for the delivery of therapeutic agents for the treatment or prevention of diseases affecting the immune system or hematologic system
Pseudo MarkGENE CAPS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 18, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCalimmune, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPasadena, CA 93551

Trademark Events

Event DateEvent Description
Monday, May 23, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, May 20, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, October 27, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 27, 2021NON-FINAL ACTION E-MAILED
Wednesday, October 27, 2021NON-FINAL ACTION WRITTEN
Wednesday, September 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 29, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 31, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 31, 2021NON-FINAL ACTION E-MAILED
Wednesday, March 31, 2021NON-FINAL ACTION WRITTEN
Tuesday, March 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 25, 2021ASSIGNED TO LIE
Monday, November 23, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 30, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 30, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 30, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 23, 2020NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Friday, October 23, 2020NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Friday, October 23, 2020REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Wednesday, September 30, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 29, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 30, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 30, 2020NON-FINAL ACTION E-MAILED
Monday, March 30, 2020NON-FINAL ACTION WRITTEN
Saturday, March 14, 2020ASSIGNED TO EXAMINER
Wednesday, December 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 18, 2019NEW APPLICATION ENTERED

Related Keywords

genecaps system prevention treatment diseases agents affecting hematologic immune therapeutic delivery